4:36 PM
 | 
Apr 25, 2017
 |  BC Extra  |  Clinical News

Interneuron strategy could lead to cell therapy for SCI

A team led by scientists at the Gladstone Institutes is the first to develop a cell culture strategy to generate V2a interneurons from human pluripotent stem cells (hPSCs), which could be used as a cell therapy to treat spinal cord injury. The group published its findings on Monday in the Proceedings of the National Academy of...

Read the full 268 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >